Monday, November 16, 2026 Vol. I · No. 4
Health · Via STAT

STAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesity

Image: STAT

How obesity medications may become the next big battleground over access to medicines in lower-income countries.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk